title: Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D(3).
authors.forename: M
authors.initials: M
authors.lastname: Kizaki
authors.forename: N
authors.initials: N
authors.lastname: Takayama
authors.forename: Y
authors.initials: Y
authors.lastname: Kawai
authors.forename: S
authors.initials: S
authors.lastname: Okamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Ikeda
mesh_terms: D000208:Acute Disease; D000368:Aged; D000753:Anemia, Refractory / Q000150:complications* / Q000188:drug therapy; D015415:Biomarkers; D001853:Bone Marrow / Q000473:pathology; D002117:Calcitriol / Q000009:adverse effects* / Q000627:therapeutic use; D019070:Cell Lineage; D015672:Erythroid Precursor Cells / Q000473:pathology; D017809:Fatal Outcome; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000145:classification; D008297:Male; D010503:Periodic Acid-Schiff Reaction; D011087:Polycythemia Vera / Q000145:classification / Q000209:etiology* / Q000473:pathology
chemical_list: D015415:Biomarkers; D006454:Hemoglobins; D002117:Calcitriol